PARP1 inhibitor (PJ34) improves the function of aging-induced endothelial progenitor cells by preserving intracellular NAD+ levels and increasing SIRT1 activity

RT @JuliaB_fitness: @rhg_1 @npure3 @Prof_M_Ristow "Treatment of db−/db− mice with NF-κB inhibitors increased eNOS activity and reduced NF-κ…

@pmullr You might enjoy the research on NAD+ & telomeres https://t.co/pmrcgWtTqj https://t.co/EzbyF1NlXe

RT @JuliaB_fitness: @rhg_1 @npure3 @Prof_M_Ristow "Treatment of db−/db− mice with NF-κB inhibitors increased eNOS activity and reduced NF-κ…

RT @JuliaB_fitness: @rhg_1 @npure3 @Prof_M_Ristow "Treatment of db−/db− mice with NF-κB inhibitors increased eNOS activity and reduced NF-κ…